- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVAX
Recent news which mentions NVAX
Why BioNTech SE And Novavax Shares Are Diving
October 18, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 18, 2022
From Benzinga
Got $300? 3 Genius Stocks to Buy on the Dip
October 18, 2022
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
October 17, 2022
From Benzinga
Should You Buy the Nasdaq's 4 Worst-Performing Stocks of 2022?
October 16, 2022
From Motley Fool
Why Novavax Stock Had an Ugly Friday
October 14, 2022
From Motley Fool
Microsoft To $325? Plus This Analyst Sees BlackRock Dropping By 15%
October 14, 2022
From Benzinga
Fresh data supports updated boosters targeting omicron subvariants, raising hopes more Americans will get the shot
October 13, 2022
From MarketWatch
KnowBe4 (KNBE) Stock Jumps 12% on Take-Private Deal
October 12, 2022
From InvestorPlace
Long COVID is a ‘very serious’ crisis, says head of WHO as he urges world leaders to act now
October 12, 2022
Tickers
NVAX
Tags
NVAX
From MarketWatch
Why Is Novavax (NVAX) Stock in the Spotlight Today?
October 12, 2022
From InvestorPlace
5 Investors Betting Big on Novavax (NVAX) Stock
October 11, 2022
From InvestorPlace
Novavax (NVAX) Stock Pops 8% With Vaccine Talks Underway
October 11, 2022
Tickers
NVAX
From InvestorPlace
Jim Cramer Says Stay Away From This Cybersecurity Company; He's Been 'Against Them The Whole Way Down'
October 11, 2022
From Benzinga
From Benzinga
Dear NVAX Stock Fans, Mark Your Calendars for Oct. 11
October 10, 2022
From InvestorPlace
Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session
October 10, 2022
From Benzinga
From Benzinga
From Benzinga
These 2 Growth Stocks Have Fallen Out of Grace. Are They Buys?
September 29, 2022
From Motley Fool
A Shot of NVAX Stock Is NOT What Your Portfolio Needs
September 28, 2022
Tickers
NVAX
From InvestorPlace
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
September 28, 2022
From Benzinga
Ryder System, Harrow Health And Other Big Gainers From Tuesday
September 28, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.